Eli Lilly and Company
Eli Lilly and Company (LLY) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · LLY · as of Sep 30, 2024
Ownership Breakdown
3,801
Institutional Holders
▲ 103 vs Q2
$687.03B
Total Inst. Value
▼ $19.59B vs Q2
941.74M
Shares Outstanding
freeFloat 89.95%
789.62M
13F Shares Held
▲ 8.50M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
LLY largest shareholders · institutional ownership
Q3 2024 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
LILLY ENDOWMENT INC pharmaceutical preparations | 96.89M | 10.75% | 10.75% | $85.84T | Oct 3, 2024 | ▼ 475.4K |
VANGUARD GROUP INC pharmaceutical preparations | 73.77M | 8.19% | 8.19% | $65.36T | Nov 13, 2024 | ▼ 85.5K |
BLACKROCK, INC. pharmaceutical preparations | 64.34M | 7.14% | 7.14% | $57.00T | Nov 13, 2024 | NEW |
PNC FINANCIAL SERVICES GROUP, INC. pharmaceutical preparations | 51.36M | 5.70% | 5.70% | $45.50T | Nov 8, 2024 | ▼ 44.1K |
STATE STREET CORP pharmaceutical preparations | 33.85M | 3.76% | 3.76% | $29.99T | Nov 14, 2024 | ▼ 25.3K |
FMR LLC pharmaceutical preparations | 33.04M | 3.67% | 3.67% | $29.27T | Nov 13, 2024 | ▼ 451.6K |
PRICE T ROWE ASSOCIATES INC /MD/ pharmaceutical preparations | 20.93M | 2.32% | 2.32% | $18.54T | Nov 14, 2024 | ▲ 278.6K |
CAPITAL WORLD INVESTORS pharmaceutical preparations | 20.36M | 2.26% | 2.26% | $18.03T | Nov 13, 2024 | ▼ 1.46M |
JPMORGAN CHASE & CO pharmaceutical preparations | 18.27M | 2.03% | 2.03% | $16.18T | Dec 26, 2024 | ▼ 597.4K |
PRIMECAP MANAGEMENT CO/CA/ pharmaceutical preparations | 17.69M | 1.96% | 1.96% | $15.67T | Nov 8, 2024 | ▼ 1.93M |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2024 vs prior quarter
Q3 2024
23
Increased
+18.08M shares1
New Positions
first time holders25
Decreased
−8.97M shares0
Sold Out
fully exitedNet shares change (top 50)
+9.11M
+18.08M / −8.97M
Net new holders
-1
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
LLY insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
0
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Sulzberger Gabrielle director | May 18, 2026 | Award | 5.018 | $988.09 | $5.0K | 3.0K | Form 4 ↗ |
LUCIANO JUAN R director | May 18, 2026 | Award | 16.109 | $988.09 | $15.9K | 16.9K | Form 4 ↗ |
Fyrwald J Erik director | May 18, 2026 | Award | 10.036 | $988.09 | $9.9K | 75.3K | Form 4 ↗ |
Alvarez Ralph director | May 18, 2026 | Award | 12.566 | $988.09 | $12.4K | 55.6K | Form 4 ↗ |
LILLY ENDOWMENT INC Former 10% Shareholder | May 6, 2026 | Sale | 13,620 | $995.23 | $13.55M | 91.88M | Form 4 ↗ |
LILLY ENDOWMENT INC Former 10% Shareholder | May 6, 2026 | Sale | 2,208 | $996.18 | $2.20M | 91.88M | Form 4 ↗ |
Sulzberger Gabrielle director | Apr 20, 2026 | Award | 5.39 | $919.90 | $5.0K | 3.0K | Form 4 ↗ |
LUCIANO JUAN R director | Apr 20, 2026 | Award | 17.303 | $919.90 | $15.9K | 16.8K | Form 4 ↗ |
Fyrwald J Erik director | Apr 20, 2026 | Award | 10.78 | $919.90 | $9.9K | 75.3K | Form 4 ↗ |
Alvarez Ralph director | Apr 20, 2026 | Award | 13.498 | $919.90 | $12.4K | 55.6K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Eli Lilly and Company (LLY) is primarily owned by institutional investors, who hold approximately 83.8% of total shares outstanding. Company insiders own approximately 10.05%, while retail and public investors account for the remaining 6.10%.
The largest institutional shareholder of Eli Lilly and Company is LILLY ENDOWMENT INC, holding approximately 96.89 million shares — equal to 10.75% of outstanding shares — as of September 30, 2024.
A total of 3,801 institutional investors currently hold LLY stock, with a combined institutional value of approximately $687.03 billion as of the most recent 13F filing period.
Frequently asked questions
LLY ownershipEli Lilly and Company (LLY) is primarily owned by institutional investors, who hold approximately 83.8% of shares. The largest shareholder is LILLY ENDOWMENT INC with a 10.75% stake. Company insiders hold 10.05%. Data sourced from SEC Form 13F as of September 30, 2024.